维普中文期刊产品整合服务
114篇 您的检索式:作者名="Brett B"
    题名 作者 年代 出处 被引量
1每日1次利拉鲁肽与每日2次艾塞那肽治疗2型糖尿病比较:一项为期26周的随机、平行组、多国开放标记试验(LEAD-6)显示文摘背景与大多数抗高血糖药物不同,胰高血糖素样肽-1(GLP-1)受体激动剂的药理作用依赖于葡萄糖水平,并且有助于减轻患者体重。本研究比较了利拉鲁肽(一种人GLP-1类似物)与艾塞那肽(一种基于醋酸艾塞那肽的GLP-1受体激动剂)治疗2型糖尿病的疗效和安全性。方法对于用最大耐受剂量二甲双胍或(和)磺脲仍控制不良的2型糖尿病成年患者,根据之前服用的抗糖尿病药物进行分层,并随机分配这些患者额外接受利拉鲁肽1.8mg每El1次(n=233)或艾塞那肽10μg每日2次(n=231),进行为期26周的开放标记、平行组、多国(15个国家)研究。主要终点是糖化血红蛋白(HbA1c)水平的变化,疗效分析采用意向性治疗分析。本试验在Clinical Trial.gov注册,注册号为NCT00518882。结果受试者的HbA1c平均基线水平为8.2%。与艾塞那肽相比,利拉鲁肽能显著降低HbA1c平均水平[-1.12%(s=0.08%)vs-0.79%(s=0.08%);疗效差异估计值为-0.33%,95%CI-0.47%~-0.18%;P〈0.0001],并且利拉鲁肽组有更多患者HbA1c水平低于7%(54%vs543%;OR 2.02,95%CI 1.31~3.11;P=0.0015)。利拉鲁肽降低平均空腹血糖的能力也显著优于艾塞那肽[-1.61mmol/Lb=0.20)vs-0.60mmol/L(s=0.20);疗效差异估计值为-1.01mmol/L,95%CI-1.37—-0.65;P〈0.0001],但是其降低早餐和晚餐后血糖的能力较艾塞那肽差。两种药物促进患者体重减轻的作用相似(利拉鲁肽组~3.24kg vs艾塞那肽组-2.87地)。耐受性均较好,但与艾塞那肽组相比,利拉鲁肽组患者恶心的持续时间较短(估计的治疗相关事件率比值为0.448,P〈0.0001),轻度低血糖的发生率也较低(每患者每年的事件发生数为1.93vs2.60;发生率比值为0.55,95%C10.34~0.88:P=0.0131;轻度低血糖的发生率为25.5%掷33.6%)。2例同时注射艾塞那肽和一种磺脲类药物的患者发生了严重的低血糖。结论相对于艾塞那肽每日2次,利拉鲁肽每日1次能显著改善血糖控制水平,且患者的耐受性更好。研究结果提示利拉鲁肽或许是2型糖尿病的一种治疗选择,特别是在减轻体重和低血糖风险作为主要考虑因素的情况下。John B Buse Julia Rosenstock Giorgio Sesti Wolfgang E Schmidt Eduard Montanya Jason H Brett Marcin Zychma Lawrence Blonde 赵乐(译) 2009世界临床医学2009,,11:3
2Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)显示文摘John B Buse Julio Rosenstock Giorgio Sesti Wolfgang E Schmidt Eduard Montanya Jason H Brett Marcin Zychma Lawrence Blonde 2009The Lancet2009,,9683:2
3MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca^sup 2+^ overload and cell death显示文摘Aurora Arin B Mahmoud Ahmed I Luo Xiang Johnson Brett A van Rooij Eva Matsuzaki Satoshi Humphries Kenneth M Hill Joseph A Bassel-Duby Rhonda Sadek Hesham A Olson Eric N 2012EN2012,,4:2
4System identification of nonlinear state - space models 显示文摘T B Schon Adrian Wills Brett Ninness 2011Automatica2011,47,:1
5Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)显示文摘John B Buse Julio Rosenstock Giorgio Sesti Wolfgang E Schmidt Eduard Montanya Jason H Brett Marcin Zychma Lawrence Blonde 2009The Lancet . 2009 (9683)2009,,9683:1
6Targeting the type III secretion system to treat bacterial infections显示文摘Marshall N C Brett F B 2014Expert Opinion on Therapeutic Targets2014,18,2:1
7Characterisation by EIS of ternary Mg alloys synthesized by mechanical alloying显示文摘CHRISTOPHER M A BRETT DIAS L TR1NDADE B FISCHER R M1ES S 2006Electrochimica Acta2006,51,:1
8Cooperative distributed model predictive control显示文摘Brett T Stewart A N Venkat J B 2010Systems & Control Letters2010,2,59:1
9Use of temperature programming to im-prove resolution of inorganic anions,haloacetic acids and oxyhalides in drinking water by suppressed ion chromatography显示文摘LEON B BRETT P 2005J Chromatography A2005,1072,2:1
10Leung enhancing thoracic lymphadenopathy uncommon etiologies but limited diagnostic considerations 显示文摘Micheal B Gotway Brett M 2005Images Pulmonary Medicine2005,12,3:1
11An automated handling system for soft compact shaped non-rigid products 显示文摘Stone R S Brett P N Evans B S 1998Mechatronics1998,8,2:1
12Electrochemical Oxidation of Mn/MnO Films:Formation of an Electrochemical Capacitor显示文摘DJURFORS B BROUGHTON J N BRETT M J 2005Acta Materialia2005,53,4:1
13Patterns and mechanisms of phytoplankton variability in Lake Washing- ton (USA) 显示文摘Arhonditsis G B Winder M Brett M T 2004Water Research2004,38,:1
14Magnetostratigraphy susceptibility of the Upper Ordovician Kope Formation, North- ern Kentucky显示文摘Ellwood B B Brett C E Macdonald W D 2007Palaeogeography Palaeoclimatology Palaeo- ecology2007,243,12:1
15An Automated Han dling System for Soft Compact Shaped Non-rigid Prod- ucts显示文摘Stone R S Brett P N Evans B S 1998Mechatronics1998,8,2:1
16The emergence of entrepre- neurship policy 显示文摘Brett A G David B A Patricia P M 2004Small Business Economics2004,22,34:1
17Can innate immunity be enhanced to treat microbial infections 显示文摘Brett B Finlay Robert E W Hancock 2000Microbiology2000,2,:1
18Defensins in the immunology of bacterial infections显示文摘Menendez A Brett Finlay B 2007Curr Opin Immunol2007,19,4:1
19Tensor decompositions and applications 显示文摘Tamara G K Brett W B 2009SIAM Review2009,51,3:1
20Molecular mechanisms of Escherichia colipathogcnicity显示文摘Croxen MA Brett B 2012Nat Rev Micmbiol2012,8,1:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费